Diagnosis and Treatment of Ovarian Cancer
According to the American Cancer Society, over 25,000 women are diagnosed with ovarian cancer each year in the United States.
Stanford Expertise
Ovarian cancer patients at the Stanford Cancer Center benefit from comprehensive combined modality treatment that includes advanced surgical techniques and the most up-to-date chemotherapeutic agents:
- Meticulous surgical debulking involving the use of state-of-the-art ultrasonic aspirators or laser beams leaves only microscopic residual.
- The newest drugs, such as Taxol.
- Our doctors are also investigating the use of intraperitoneal chemotherapy. Direct intraperitoneal administration increases tumor exposure to cytotoxic agents or biological response modifiers, and has been theorized to offer improved survival rates in preliminary studies.
Other protectors or agents reducing the toxicities of standard chemotherapy are also available.
Additionally, intra-operative radiation therapy (IORT) during surgery can improve outcomes.
Fertility-conserving surgery and advanced assisted reproductive technology are also an intergrated part of ovarian cancer treatment at the Stanford Cancer Center, to help maximize your child-bearing options whenever possible.
Trial Administration